EP1425383A4 - Stabilisation de cellules et de specimens biologiques pour l'analyse - Google Patents
Stabilisation de cellules et de specimens biologiques pour l'analyseInfo
- Publication number
- EP1425383A4 EP1425383A4 EP02768676A EP02768676A EP1425383A4 EP 1425383 A4 EP1425383 A4 EP 1425383A4 EP 02768676 A EP02768676 A EP 02768676A EP 02768676 A EP02768676 A EP 02768676A EP 1425383 A4 EP1425383 A4 EP 1425383A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- analysis
- damage
- cells
- vitro
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31415101P | 2001-08-23 | 2001-08-23 | |
US314151P | 2001-08-23 | ||
US36962802P | 2002-04-03 | 2002-04-03 | |
US369628P | 2002-04-03 | ||
PCT/US2002/026867 WO2003018757A2 (fr) | 2001-08-23 | 2002-08-23 | Stabilisation de cellules et de specimens biologiques pour l'analyse |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1425383A2 EP1425383A2 (fr) | 2004-06-09 |
EP1425383A4 true EP1425383A4 (fr) | 2005-11-09 |
Family
ID=26979228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02761478A Expired - Lifetime EP1425294B2 (fr) | 2001-08-23 | 2002-08-23 | Analyse de cellules tumorales en circulation, de fragments et de debris associes |
EP02768676A Withdrawn EP1425383A4 (fr) | 2001-08-23 | 2002-08-23 | Stabilisation de cellules et de specimens biologiques pour l'analyse |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02761478A Expired - Lifetime EP1425294B2 (fr) | 2001-08-23 | 2002-08-23 | Analyse de cellules tumorales en circulation, de fragments et de debris associes |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1425294B2 (fr) |
JP (3) | JP2005501236A (fr) |
KR (2) | KR20040053115A (fr) |
CN (2) | CN1596265A (fr) |
AT (1) | ATE401574T1 (fr) |
AU (2) | AU2008288601B2 (fr) |
BR (2) | BR0212125A (fr) |
CA (2) | CA2457894C (fr) |
DE (1) | DE60227678D1 (fr) |
IL (2) | IL160209A0 (fr) |
WO (2) | WO2003018757A2 (fr) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003018757A2 (fr) * | 2001-08-23 | 2003-03-06 | Immunivest Corporation | Stabilisation de cellules et de specimens biologiques pour l'analyse |
US7863012B2 (en) | 2004-02-17 | 2011-01-04 | Veridex, Llc | Analysis of circulating tumor cells, fragments, and debris |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
CA2484876C (fr) | 2002-05-13 | 2011-11-22 | Becton, Dickinson And Company | Systeme de prelevement d'echantillon comprenant un inhibiteur de protease |
ATE531257T1 (de) | 2002-09-27 | 2011-11-15 | Gen Hospital Corp | Mikrofluidische vorrichtung zur zelltrennung und verwendungen davon |
CA2445204C (fr) | 2002-10-16 | 2014-08-12 | Streck Laboratories, Inc. | Methode et dispositif de prelevement et de conservation de cellules aux fins d'analyse |
WO2004076643A2 (fr) | 2003-02-27 | 2004-09-10 | Immunivest Corporation | Cellules tumorales circulantes (ctc): evaluation precoce du temps d'evolution, de la survie et de la reaction aux therapies des patients cancereux metastasiques |
JP4629675B2 (ja) * | 2003-09-18 | 2011-02-09 | ベリデックス・リミテッド・ライアビリティ・カンパニー | オペレーター不要のプログラム可能な試料調製および分析システム |
EP1861509B1 (fr) * | 2005-03-14 | 2015-09-09 | Janssen Diagnostics, LLC | Méthode de prédiction de survie sans progression et de survie globale, à chaque instant du suivi, au cours du traitement de patientes atteintes du cancer du sein métastatique, utilisant des cellules tumorales circulantes |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
CN104673905B (zh) | 2005-06-20 | 2016-09-07 | 领先细胞医疗诊断有限公司 | 检测单个细胞中的核酸和鉴定异质大细胞群中罕见细胞的方法 |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
WO2011050103A1 (fr) | 2009-10-21 | 2011-04-28 | The Scripps Research Institute | Méthodes d'utilisation de cellules non rares pour détecter des cellules rares |
US8337755B2 (en) | 2006-03-13 | 2012-12-25 | Veridex, Llc | Operator independent programmable sample preparation and analysis system |
KR101467136B1 (ko) * | 2006-06-02 | 2014-12-01 | 화이자 프로덕츠 인코포레이티드 | 순환 종양 세포 분석 |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
EP2029779A4 (fr) | 2006-06-14 | 2010-01-20 | Living Microsystems Inc | Utilisation de génotypage snp fortement parallèle pour diagnostic fétal |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
CA2657621A1 (fr) | 2006-07-14 | 2008-01-17 | Aviva Biosciences Corporation | Procedes et compositions servant a detecter des cellules rares dans un echantillon biologique |
CN101669031A (zh) * | 2007-02-27 | 2010-03-10 | 森托科隆股份公司 | 使用与细胞外标记物结合的试剂组多重检测肿瘤细胞 |
WO2008128243A1 (fr) | 2007-04-16 | 2008-10-23 | Immunivest Corporation | Procédé rapide semi-automatisé pour détecter des cellules infectées de virus dans des spécimens directs |
US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
US7828968B2 (en) | 2007-08-30 | 2010-11-09 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
US8110101B2 (en) | 2007-08-30 | 2012-02-07 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
WO2009076560A2 (fr) | 2007-12-12 | 2009-06-18 | The Board Of Trustees Of The Leland Stanford Junior University | Procédé et appareil pour la séparation magnétique de cellules |
EP2952589B1 (fr) | 2008-09-20 | 2018-02-14 | The Board of Trustees of The Leland Stanford Junior University | Diagnostic non invasif d'une aneuploïdie foetale par séquençage |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
DE202010018569U1 (de) | 2009-02-18 | 2017-09-26 | Streck Inc. | Konservierung zellfreier Nukleinsäuren |
US20130023433A1 (en) | 2009-09-28 | 2013-01-24 | Yuling Luo | Methods of detecting nucleic acid sequences with high specificity |
EP2529030B1 (fr) | 2010-01-29 | 2019-03-13 | Advanced Cell Diagnostics, Inc. | Methode de detection d'acides nucleiques in situ |
JPWO2011099565A1 (ja) * | 2010-02-10 | 2013-06-17 | シスメックス株式会社 | 血液中癌細胞の検出方法及びそれに用いるプログラム |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
EP2854058A3 (fr) | 2010-05-18 | 2015-10-28 | Natera, Inc. | Procédés pour une classification de ploïdie prénatale non invasive |
US10179937B2 (en) | 2014-04-21 | 2019-01-15 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
DE102010020785A1 (de) * | 2010-05-18 | 2011-11-24 | Siemens Aktiengesellschaft | Vorrichtung und Verfahren zum Erkennen von magnetisch markierten Mikroobjekten |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
EP2704740B1 (fr) | 2011-05-04 | 2016-10-05 | Streck, Inc. | Virus grippal porcin inactivé et procédés de préparation |
WO2013016600A2 (fr) * | 2011-07-28 | 2013-01-31 | The Trustees Of The University Of Pennsylvania | Méthodes et réactifs pour le diagnostic d'états pathologiques et la caractérisation de cellules tumorales associées à des liquides séreux |
JP6155269B2 (ja) | 2011-09-26 | 2017-06-28 | プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 細胞外核酸の安定化および単離 |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
KR102037891B1 (ko) * | 2012-03-09 | 2019-10-30 | 한국전자통신연구원 | 다중 분리 장치 및 혈중 암세포 분리 방법 |
EP2848935A4 (fr) * | 2012-05-10 | 2015-12-09 | Konica Minolta Inc | Procédé d'élimination des globules rouges ainsi que tube de centrifugation pour prélèvement sanguin |
US10724074B2 (en) | 2012-09-25 | 2020-07-28 | Qiagen Gmbh | Stabilisation of biological samples |
EP2971279B1 (fr) | 2013-03-15 | 2019-11-13 | The Trustees of Princeton University | Méthodes et dispositifs de purification à rendement élevé |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
US11493428B2 (en) | 2013-03-15 | 2022-11-08 | Gpb Scientific, Inc. | On-chip microfluidic processing of particles |
CN105121643A (zh) * | 2013-03-18 | 2015-12-02 | 凯杰有限公司 | 细胞外核酸的稳定化和分离 |
EP3447141B1 (fr) | 2013-03-18 | 2020-08-05 | PreAnalytiX GmbH | Stabilisation d'échantillons biologiques |
WO2015013244A1 (fr) * | 2013-07-24 | 2015-01-29 | Streck, Inc. | Compositions et méthodes de stabilisation de cellules tumorales circulantes |
US10053692B2 (en) | 2013-10-21 | 2018-08-21 | The General Hospital Corporation | Methods relating to circulating tumor cell clusters and the treatment of cancer |
WO2015112955A1 (fr) | 2014-01-27 | 2015-07-30 | Epic Sciences, Inc. | Diagnostics de cellules tumorales circulantes pour biomarqueurs du cancer de la prostate |
EP3108246B1 (fr) | 2014-02-21 | 2019-10-09 | Epic Sciences, Inc. | Méthodes pour analyser des cellules circulantes rares |
EP4218411A3 (fr) * | 2014-03-18 | 2023-08-23 | PreAnalytiX GmbH | Stabilisation et isolement d'acides nucléiques extracellulaires |
CN103940997B (zh) * | 2014-03-21 | 2017-01-04 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
CN103980365A (zh) * | 2014-06-03 | 2014-08-13 | 国家纳米科学中心 | 一种表面固载炭疽致死因子的磁性纳米粒子、其制备方法及用途 |
EP3164204B1 (fr) * | 2014-07-02 | 2021-03-10 | Siemens Healthcare Diagnostics Inc. | Séparation d'acides nucléiques sélective |
WO2016137915A1 (fr) * | 2015-02-24 | 2016-09-01 | Siemens Healthcare Diagnostics Inc. | Préfixation permettant d'augmenter la récupération de cellules rares |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
WO2016183106A1 (fr) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Procédés et compositions pour la détermination de la ploïdie |
US20170097361A1 (en) * | 2015-07-15 | 2017-04-06 | Streck, Inc. | Method and device for stabilizing of proteins |
JP6617495B2 (ja) * | 2015-09-18 | 2019-12-11 | 東ソー株式会社 | 腫瘍細胞の検出方法 |
US20180328848A1 (en) * | 2015-11-04 | 2018-11-15 | Axon Dx, Llc | Cell detection, capture, analysis, aggregation, and output methods and apparatus |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
CA3005694A1 (fr) | 2015-11-20 | 2017-05-26 | Qiagen Gmbh | Procede de preparation de compositions sterilisees d'acides nucleiques extracellulaires |
CN105372109A (zh) * | 2015-12-15 | 2016-03-02 | 苏州药明康德新药开发股份有限公司 | 添加稳定剂的生物基质的制备方法 |
WO2017152028A1 (fr) * | 2016-03-04 | 2017-09-08 | Janssen Diagnostics, Llc | Conservation de composants cellulaires de cellules avec un conservateur |
WO2017155894A1 (fr) | 2016-03-07 | 2017-09-14 | Cfgenome, Llc | Témoins moléculaires non invasifs |
JP2017219479A (ja) | 2016-06-09 | 2017-12-14 | 住友電気工業株式会社 | 微小粒子計測装置及び分析方法 |
US11506655B2 (en) | 2016-07-29 | 2022-11-22 | Streck, Inc. | Suspension composition for hematology analysis control |
WO2018067517A1 (fr) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Procédés pour caractériser une variation de nombre de copies à l'aide d'un séquençage de ligature de proximité |
US10415080B2 (en) | 2016-11-21 | 2019-09-17 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
RU2764245C2 (ru) * | 2017-08-02 | 2022-01-14 | Зарштедт Аг Унд Ко. Кг | Способ и состав для стабилизации нуклеиновых кислот, свободных от клеток, и клеток |
JP7393328B2 (ja) | 2017-09-01 | 2023-12-06 | ジーピービー・サイエンティフィック・インコーポレイテッド | マイクロ流体を使用した治療的に活性な細胞を調製する方法 |
EP3697209A4 (fr) * | 2017-10-19 | 2021-07-28 | Streck, Inc. | Compositions pour l'hémolyse et la régulation de la coagulation et la stabilisation de vésicules extracellulaires |
SG11202011274YA (en) | 2018-05-14 | 2020-12-30 | Nanostring Technologies Inc | Chemical compositions and methods of using same |
JP7334468B2 (ja) * | 2018-05-29 | 2023-08-29 | 東ソー株式会社 | 血液試料保存剤 |
JP7036670B2 (ja) | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN108865976B (zh) * | 2018-07-19 | 2022-06-28 | 复旦大学附属中山医院 | 一种离散汲取收集外泌体(exosome)的方法及试剂 |
CN110250159A (zh) * | 2019-05-28 | 2019-09-20 | 天津中科生物科技有限公司 | 一种细胞保护液及其制备方法和应用 |
JP7355473B1 (ja) | 2022-03-25 | 2023-10-03 | 積水メディカル株式会社 | 循環腫瘍細胞分離キット、循環腫瘍細胞分離容器及び循環腫瘍細胞の分離方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (fr) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Agent de lyse pour l'analyse de cellules sanguines périphériques |
WO1993005650A1 (fr) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Procedes et compositions comportant une solution de stabilisation a l'aldehyde |
WO1994018828A1 (fr) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Systeme de reactifs polyvalent de lyse rapide d'echantillon de sang total |
WO1997008557A1 (fr) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Procede efficace d'enrichissement et de detection de cellules tumorales disseminees |
WO1997045729A1 (fr) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Liquide servant a recueillir un specimen |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040785A (en) * | 1976-10-18 | 1977-08-09 | Technicon Instruments Corporation | Lysable blood preservative composition |
US4320111A (en) * | 1977-06-14 | 1982-03-16 | American Home Products Corporation | Immunologic compositions methods of preparation and use |
FR2523810B1 (fr) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | Tissu biologique greffable et procede pour sa preparation |
FR2528848A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique |
EP0156537A3 (fr) * | 1984-03-02 | 1987-05-13 | Board Of Regents University Of Texas System | Fluide magnétique biologique |
US4788139A (en) * | 1987-08-06 | 1988-11-29 | Streck Laboratories, Inc. | Platelet aggregation reagent, reagent container and method of determining platelet aggregation in EDTA-anticoagulated blood |
US5385707A (en) * | 1988-12-28 | 1995-01-31 | Stefan Miltenyi | Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same |
US5698271A (en) * | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US6670197B2 (en) * | 1997-11-24 | 2003-12-30 | David L. Rimm | Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments |
AU760560B2 (en) * | 1998-02-12 | 2003-05-15 | Board Of Regents, The University Of Texas System | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
AU2876900A (en) * | 1999-02-10 | 2000-08-29 | Cell Works Inc. | Class characterization of circulating cancer cells isolated from body fluids andmethods of use |
WO2001019956A2 (fr) * | 1999-09-13 | 2001-03-22 | Bander Neil H | Procede d'isolement de cellules epitheliales prostatiques du sperme |
WO2003018757A2 (fr) * | 2001-08-23 | 2003-03-06 | Immunivest Corporation | Stabilisation de cellules et de specimens biologiques pour l'analyse |
-
2002
- 2002-08-23 WO PCT/US2002/026867 patent/WO2003018757A2/fr active Application Filing
- 2002-08-23 CA CA2457894A patent/CA2457894C/fr not_active Expired - Fee Related
- 2002-08-23 CN CNA028212002A patent/CN1596265A/zh active Pending
- 2002-08-23 DE DE60227678T patent/DE60227678D1/de not_active Expired - Lifetime
- 2002-08-23 JP JP2003523608A patent/JP2005501236A/ja active Pending
- 2002-08-23 WO PCT/US2002/026861 patent/WO2003019141A2/fr active Application Filing
- 2002-08-23 KR KR10-2004-7002473A patent/KR20040053115A/ko not_active Application Discontinuation
- 2002-08-23 JP JP2003523961A patent/JP2005502863A/ja active Pending
- 2002-08-23 IL IL16020902A patent/IL160209A0/xx unknown
- 2002-08-23 BR BR0212125-5A patent/BR0212125A/pt not_active IP Right Cessation
- 2002-08-23 BR BR0212124-7A patent/BR0212124A/pt not_active Application Discontinuation
- 2002-08-23 EP EP02761478A patent/EP1425294B2/fr not_active Expired - Lifetime
- 2002-08-23 EP EP02768676A patent/EP1425383A4/fr not_active Withdrawn
- 2002-08-23 CN CNA02820820XA patent/CN1571634A/zh active Pending
- 2002-08-23 CA CA2457891A patent/CA2457891C/fr not_active Expired - Fee Related
- 2002-08-23 AT AT02761478T patent/ATE401574T1/de not_active IP Right Cessation
- 2002-08-23 IL IL16021002A patent/IL160210A0/xx unknown
- 2002-08-23 KR KR10-2004-7002572A patent/KR20040030984A/ko not_active Application Discontinuation
-
2008
- 2008-12-24 AU AU2008288601A patent/AU2008288601B2/en not_active Ceased
-
2009
- 2009-01-02 AU AU2009200013A patent/AU2009200013B2/en not_active Ceased
- 2009-01-21 JP JP2009011194A patent/JP2009109514A/ja active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (fr) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Agent de lyse pour l'analyse de cellules sanguines périphériques |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
WO1993005650A1 (fr) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Procedes et compositions comportant une solution de stabilisation a l'aldehyde |
WO1994018828A1 (fr) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Systeme de reactifs polyvalent de lyse rapide d'echantillon de sang total |
WO1997008557A1 (fr) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Procede efficace d'enrichissement et de detection de cellules tumorales disseminees |
WO1997045729A1 (fr) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Liquide servant a recueillir un specimen |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Also Published As
Publication number | Publication date |
---|---|
IL160209A0 (en) | 2004-07-25 |
EP1425294B2 (fr) | 2012-12-12 |
CA2457891A1 (fr) | 2003-03-06 |
EP1425294A4 (fr) | 2005-11-16 |
AU2009200013B2 (en) | 2012-03-08 |
EP1425383A2 (fr) | 2004-06-09 |
KR20040053115A (ko) | 2004-06-23 |
JP2009109514A (ja) | 2009-05-21 |
WO2003018757A2 (fr) | 2003-03-06 |
ATE401574T1 (de) | 2008-08-15 |
IL160210A0 (en) | 2004-07-25 |
EP1425294B1 (fr) | 2008-07-16 |
AU2009200013A1 (en) | 2009-02-05 |
BR0212125A (pt) | 2005-06-28 |
BR0212124A (pt) | 2004-07-20 |
KR20040030984A (ko) | 2004-04-09 |
WO2003018757A3 (fr) | 2003-09-12 |
JP2005502863A (ja) | 2005-01-27 |
DE60227678D1 (de) | 2008-08-28 |
WO2003019141A2 (fr) | 2003-03-06 |
WO2003019141A3 (fr) | 2004-04-01 |
CN1596265A (zh) | 2005-03-16 |
EP1425294A2 (fr) | 2004-06-09 |
AU2008288601A1 (en) | 2009-04-02 |
AU2008288601B2 (en) | 2012-05-31 |
CA2457894C (fr) | 2014-07-08 |
CA2457894A1 (fr) | 2003-03-06 |
CA2457891C (fr) | 2019-10-01 |
CN1571634A (zh) | 2005-01-26 |
JP2005501236A (ja) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160210A0 (en) | Stabilization of cells and biological specimens for analysis | |
Lazar et al. | Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line | |
EP2169387B1 (fr) | Procédé multiparamètre haute sensibilité pour l'analyse d'événements rares dans un échantillon biologique | |
NZ333830A (en) | Method for assessing chemosensitivity of a biopsy sample | |
WO2008109414A3 (fr) | Utilisation de la fluorescence endogène pour identifier les cellules de tumeur du sein métastatiques envahissantes | |
de Paz et al. | The relationship between ram sperm head morphometry and fertility depends on the procedures of acquisition and analysis used | |
Kervarrec et al. | Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome | |
Baker et al. | Rapid cervical cytology screening | |
Subramanian et al. | Significance of bone marrow fibrosis in multiple myeloma | |
Teman et al. | Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study | |
WO2003023354A3 (fr) | Identification et quantification des types de lymphocytes sur la base de la morphologie de leurs noyaux au moyen de systemes de disques biologiques optiques | |
Pijanka et al. | Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy | |
Cattan et al. | Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis | |
Böttger et al. | DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus? | |
Simons et al. | Effects of histological staining on the analysis of human DNA from archived slides | |
Gong et al. | Clonal status and clinicopathological features of Langerhans cell histiocytosis | |
Zver et al. | Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia | |
WO2011033290A3 (fr) | Essai par fluorescence double | |
Toman | What are the advantages and disadvantages of fluorescence microscopy | |
Zver et al. | Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry | |
Shen et al. | Accurate and noninvasive embryos screening during in vitro fertilization (IVF) assisted by Raman analysis ofembryos culture medium | |
Balasubramanian et al. | Isolation and characterization of circulating tumor cells (CTCs) from peripheral blood specimens of patients with advanced solid tumor malignancies (using ApoStream (TM) instrumentation) | |
Zickuhr et al. | Spatial Metabolomics co-registered with Multiplex Phenotyping for the Evaluation of Human Kidney Tissue | |
Dao et al. | Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging | |
HK1049204A1 (en) | Cytological imaging system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040315 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050927 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 B Ipc: 7G 01N 33/574 B Ipc: 7G 01N 33/543 A |
|
17Q | First examination report despatched |
Effective date: 20060623 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080508 |